2022 Sees Record-breaking Marketplace Enrollment
14.5M Americans signed up for health insurance during open enrollment for the Affordable Care Act Marketplace, a 21% increase from 2021 (link). Additionally, 3M people are newly insured, up 17% from last year. The American Rescue Plan (ARP) is primarily to thank for these positive numbers. Why the Increase? The ARP expanded tax credits for…
Read MoreHospital Bed & Breakfast
POLICY Hospital Bed & Breakfast MyMichigan Health announced it will officially launch a hospital at home (HaH) program, joining 100+ other U.S. hospitals that are trying to deliver high-value care. While the HaH concept has been around for over two decades, only now is it starting to take off. HaH 101HaH programs allow for intensive…
Read MoreTravel Often?
Travel Often? Travel nursing agency AMN Healthcare recorded $1.36B in Q4 revenue, a 116% increase from Q4 2020 revenue (link). Even more impressive: AMN’s net income jumped 363% in 2021. The increased demand for nurses during the omicron surge is likely to thank for the uptick in revenue and net income. AMN Healthcare isn’t alone,…
Read MoreHospital Bed & Breakfast
MyMichigan Health announced it will officially launch a hospital at home (HaH) program, joining 100+ other U.S. hospitals that are trying to deliver high-value care. While the HaH concept has been around for over two decades, only now is it starting to take off. HaH 101 HaH programs allow for intensive care in the comfort…
Read MoreA New Healthcare Startup Trend: Consolidation
Specialty care telehealth platform Thirty Madison will merge with women-focused healthcare company Nurx (link). Given the digital health market is oversaturated with companies, this merger may mark the beginning of a new M&A trend in the digital health space. The DeetsThirty Madison is a specialty care company focusing on chronic conditions. The company provides care…
Read MoreBiogen Sells Out and Buys In
BUSINESS Biogen Sells Out and Buys In Biogen is selling its equity stake in a joint venture with Samsung Biologics and buying into Roche’s cancer drug mosunetuzumab. These business moves will likely bring in billions of dollars of revenue over the years, helping the company bounce back from the financial struggles of its Alzheimer’s drug…
Read More